Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)

  Print   

Friday 29 March, 2019

Benchmark Hlgs PLC

Replacement: Total Voting Rights

RNS Number : 5336U
Benchmark Holdings PLC
29 March 2019
 

The following amendment has been made to the 'Total Voting Rights' announcement released on 29 March 2019 at 7am under RNS number 4049U.

The previous announcement incorrectly stated that the Company's issued share capital consisted of 557,979,442 ordinary shares. The correct figure is stated below.

All other details remain unchanged.

The full amended text is shown below.

 

29 March 2019

Benchmark Holdings plc

("Benchmark" or "the Company")

Replacement: Total Voting Rights

In accordance with the FCA's Disclosure and Transparency Rules, the Company wishes to notify the market of the following:

As at 29 March 2019, the Company's issued share capital consisted of 557,980,027 ordinary shares of 0.1 pence each ("Ordinary Shares"), all with voting rights. No shares are currently held in treasury. The total number of voting rights in the Company as at 29 March 2019 is therefore 557,980,027.

The above figure (557,980,027 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in the Company.

 

Benchmark Holdings plc

Tel: 020 3915 1236

Malcolm Pye, CEO


Ivonne Cantu, Investor Relations Director


Rachel Aninakwah, Communications




Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)


James Black (Corporate Broking)




MHP


Katie Hunt / Reg Hoare /Alistair de Kare-Silver     

                     Tel: 020 3128 8742                                 
07551 170 451

[email protected]



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVRJLMITMBTTBJL

a d v e r t i s e m e n t